Clinical Trials Logo

Clinical Trial Summary

The objectives of the clinical trial is to validate hemodynamic parameters (Blood pressure and Cardiac Output) generated by an application coupled with an off-the-shelf pulse oximeter. The validation will be done by comparing the generated information to data gathered while performing Stress Echocardiography. The first phase of the study will be done on 10 patients undergoing a Stress Echocardiography test at the cardiology department at Meir Hospital


Clinical Trial Description

The HeartBeat system combines an FDA/CE approved watch-like Pulse Oximeter for acquiring the data and an android software application that serves as the Hemodynamic calculator. The application performs POST-PROCESSING of the PhotoPlethismoGraphic (PPG) signal (Normally the PPG signal in Pulse Oximeters is used only to compute heart rate and SpO2). The raw data is transferred from the watch oximeter to the smartphone using a standard Bluetooth protocol.

The Post-processing uses wavelet signal processing to estimate and display certain Hemodynamic parameters like Blood Pressure (BP) and Cardiac Output (CO) in a continuous and graphical way on a standard Android device. In addition to the standard heart rate and SpO2, the application displays the measured PPG signal and estimated continues BP and CO.

HeartBeat is the only device that can non-invasively estimate Continuous BP and its Cardiac Output component and the resistance component in a mobile wearable device. Differentiating between these 2 components can play a major role in helping the doctor to understand the effect of cardiovascular medications and Lifestyle interventions.

The trial will compare blood pressure and cardiac output parameters measured during Stress Echocardiography using an echo cardiograph and standard sphygmomanometer to the parameters generated by the application.

Trial goals

- Feasibility tests for the HeartBeat application as a tool for monitoring BP and CO changes over time

- Compare BP and CO parameters generated by the applications to the ones measured by standard non-invasive equipment during a Stress Echocardiography

- Calculate additional parameters such as stroke volume, systematic vascular resistance and cardiac index ;


Study Design


Related Conditions & MeSH terms


NCT number NCT02422342
Study type Observational
Source HeartBeat Technologies LTD
Contact
Status Active, not recruiting
Phase
Start date April 2015
Completion date December 31, 2019

See also
  Status Clinical Trial Phase
Recruiting NCT01157299 - Hemodynamic Evaluation of Preload Responsiveness in Children by Using PiCCO N/A
Completed NCT01857999 - Losartan in Decompensated Heart Failure Phase 4
Completed NCT02511457 - Comparison of Cardiac Output With LiDCO Rapid and TEE Against Thermodilution Technique in Cardiac Surgery N/A
Terminated NCT00524862 - Standard Drug Therapy vs. Implanted Defibrillator for Primary Prevention of Sudden Cardiac Death N/A
Completed NCT00529490 - Efficacy, Safety of Hypertonic Lactate Soln. as Fluid Resuscitation Compared With Ringer's Lactate in Post-CABG Pats Phase 3
Completed NCT02433379 - Understanding Outcomes With the EMBLEMâ„¢ S-ICD in Primary Prevention Patients With Low Ejection Fraction N/A
Completed NCT00586027 - Is There a Correlation of Natriuretic Propeptide Type B With an Intraoperative Low Cardiac Output? N/A
Completed NCT00529711 - The Efficacy of Hypertonic Lactate Solution in CABG(Coronary Artery Bypass Grafting) Patients Phase 3
Completed NCT02599376 - Comparative Study of Haemodynamic Changes After Spinal Anaesthesia in Non-obese and Pregnant Women N/A
Completed NCT02529033 - Hemodynamic Survey Cardiac Surgical Scenarios
Withdrawn NCT00167440 - Comparison of Techniques for Assessing Cardiac Output and Preload in Critically Ill Pediatric Patients Phase 3